HAL (France)open access
Oxaliplatin, ATR inhibitor and anti-PD-1 antibody combination therapy controls colon carcinoma growth, induces local and systemic changes in the immune compartment, and protects against tumor rechallenge in mice
Chimiotherapie, Neutrophil, 0
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 139718
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.